These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28266329)

  • 21. New Genetic and Genomic Approaches After the Genome-wide Association Study Era--Back to the Future.
    Ngeow J; Eng C
    Gastroenterology; 2015 Oct; 149(5):1138-41. PubMed ID: 26073374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of -omic tools in the study of disease processes in marine bivalve mollusks.
    Gómez-Chiarri M; Guo X; Tanguy A; He Y; Proestou D
    J Invertebr Pathol; 2015 Oct; 131():137-54. PubMed ID: 26021714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenomics: an updated European Research Agenda.
    Demuth A; Aharonowitz Y; Bachmann TT; Blum-Oehler G; Buchrieser C; Covacci A; Dobrindt U; Emödy L; van der Ende A; Ewbank J; Fernández LA; Frosch M; García-Del Portillo F; Gilmore MS; Glaser P; Goebel W; Hasnain SE; Heesemann J; Islam K; Korhonen T; Maiden M; Meyer TF; Montecucco C; Oswald E; Parkhill J; Pucciarelli MG; Ron E; Svanborg C; Uhlin BE; Wai SN; Wehland J; Hacker J
    Infect Genet Evol; 2008 May; 8(3):386-93. PubMed ID: 18321793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agent-based dynamic knowledge representation of Pseudomonas aeruginosa virulence activation in the stressed gut: Towards characterizing host-pathogen interactions in gut-derived sepsis.
    Seal JB; Alverdy JC; Zaborina O; An G
    Theor Biol Med Model; 2011 Sep; 8():33. PubMed ID: 21929759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput sequencing in clinical oncology: from past to present.
    Mery B; Vallard A; Rowinski E; Magne N
    Swiss Med Wkly; 2019 Mar; 149():w20057. PubMed ID: 30946479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolomics and the Microbiome as Biomarkers in Sepsis.
    Lee J; Banerjee D
    Crit Care Clin; 2020 Jan; 36(1):105-113. PubMed ID: 31733672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precision Immunotherapy for Sepsis.
    Peters van Ton AM; Kox M; Abdo WF; Pickkers P
    Front Immunol; 2018; 9():1926. PubMed ID: 30233566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The critical role of neutrophil-endothelial cell interactions in sepsis: new synergistic approaches employing organ-on-chip, omics, immune cell phenotyping and
    Liu D; Langston JC; Prabhakarpandian B; Kiani MF; Kilpatrick LE
    Front Cell Infect Microbiol; 2023; 13():1274842. PubMed ID: 38259971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computation as the mechanistic bridge between precision medicine and systems therapeutics.
    Hansen J; Iyengar R
    Clin Pharmacol Ther; 2013 Jan; 93(1):117-28. PubMed ID: 23212109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiogenomics: a key component of precision cancer medicine.
    Liu Z; Duan T; Zhang Y; Weng S; Xu H; Ren Y; Zhang Z; Han X
    Br J Cancer; 2023 Sep; 129(5):741-753. PubMed ID: 37414827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tensor Factorization for Precision Medicine in Heart Failure with Preserved Ejection Fraction.
    Luo Y; Ahmad FS; Shah SJ
    J Cardiovasc Transl Res; 2017 Jun; 10(3):305-312. PubMed ID: 28116551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approaches to modernize the combination drug development paradigm.
    Day D; Siu LL
    Genome Med; 2016 Oct; 8(1):115. PubMed ID: 27793177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying biomarkers for predicting successful embryo implantation: applying single to multi-OMICs to improve reproductive outcomes.
    Hernández-Vargas P; Muñoz M; Domínguez F
    Hum Reprod Update; 2020 Feb; 26(2):264-301. PubMed ID: 32096829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The era of genomics: impact on sepsis clinical trial design.
    Cariou A; Chiche JD; Charpentier J; Dhainaut JF; Mira JP
    Crit Care Med; 2002 May; 30(5 Suppl):S341-8. PubMed ID: 12004257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LEUKOCYTE PHENOTYPING IN SEPSIS USING OMICS, FUNCTIONAL ANALYSIS, AND IN SILICO MODELING.
    Langston JC; Yang Q; Kiani MF; Kilpatrick LE
    Shock; 2023 Feb; 59(2):224-231. PubMed ID: 36377365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What was old is new again: using the host response to diagnose infectious disease.
    Ko ER; Yang WE; McClain MT; Woods CW; Ginsburg GS; Tsalik EL
    Expert Rev Mol Diagn; 2015; 15(9):1143-58. PubMed ID: 26145249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic studies of disease-outcome in host--pathogen dynamics.
    Longo AV; Burrowes PA; Zamudio KR
    Integr Comp Biol; 2014 Sep; 54(3):427-38. PubMed ID: 24916476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. These Are the Genes You're Looking For: Finding Host Resistance Genes.
    Bourgeois JS; Smith CM; Ko DC
    Trends Microbiol; 2021 Apr; 29(4):346-362. PubMed ID: 33004258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histo-genomics: digital pathology at the forefront of precision medicine.
    Barsoum I; Tawedrous E; Faragalla H; Yousef GM
    Diagnosis (Berl); 2019 Aug; 6(3):203-212. PubMed ID: 30827078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.